Directory
>
Carl Uli Bialucha
Carl Uli Bialucha
Chief Scientific Officer | Xilio Therapeutics, Inc.
Cambridge, Massachusetts, United States
Carl Uli Bialucha
Summary
Carl Uli Bialucha is a seasoned Chief Scientific Officer at Xilio Therapeutics, Inc., specializing in cancer and immuno-oncology drug discovery. With a Ph.D. in Molecular Cell Biology from University College London, he has a robust background in biochemistry, biopharmaceuticals, and translational research. His leadership has been pivotal in guiding research teams to develop multiple clinical-stage molecules, showcasing his expertise in creating high-performing, multidisciplinary teams. Carl's career trajectory includes significant roles at renowned organizations such as Novartis and Immunitas Therapeutics, where he spearheaded innovative drug discovery initiatives. His commitment to advancing cancer therapeutics is evident through numerous publications in prestigious journals, reflecting his contributions to the field. Beyond his technical prowess, he has experience in company growth from Series A to IPO, emphasizing his business acumen in the biotech industry. Carl's passion for life sciences drives his continuous pursuit of impactful research and development in oncology.
Carl Uli Bialucha
Work Experience
Chief Scientific Officer at
Xilio Therapeutics, Inc.
August 2022 - Present
Scientific Advisory Board Member at
Terri Brodeur Breast Cancer Foundation (TBBCF)
August 2022 - Present
SVP of Research at
Xilio Therapeutics, Inc.
April 2021 - August 2022
VP, Drug Discovery at
Immunitas Therapeutics
December 2019 - April 2021
Director, Oncology Biotherapeutics at
Novartis
November 2016 - December 2019
Lab Head, Oncology Biotherapeutics at
Novartis
November 2010 - November 2016
Postdoctoral Fellow, Cancer Genetics at
Cold Spring Harbor Laboratory Association, Inc.
April 2007 - November 2010
Carl Uli Bialucha
Education
MRC Laboratory for Molecular Cell Biology (LMCB), University College London, Ph.D.
January 2002 - January 2007
University of California, San Francisco, Research Exchange Fellow
January 2003 - January 2003
University of Sussex, Bsc Hons
January 1999 - January 2002
Frequently Asked Questions about Carl Uli Bialucha
What is Carl Uli Bialucha email address?
Carl Uli Bialucha's primary email address is *********@xiliotx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Carl Uli Bialucha work for?
Carl Uli Bialucha is a Chief Scientific Officer at Xilio Therapeutics, Inc., a company specializing in Commercial physical research.
Where Carl Uli Bialucha graduated from?
Carl Uli Bialucha holds a degree in Molecular Cell Biology from MRC Laboratory for Molecular Cell Biology (LMCB), University College London.
How can I directly contact Carl Uli Bialucha?
To contact Carl Uli Bialucha directly, you can use the email address *********@xiliotx.com. Complete contact information is available upon registration with Muraena.
Who is Carl Uli Bialucha?
Carl Uli Bialucha is a seasoned Chief Scientific Officer at Xilio Therapeutics, Inc., specializing in cancer and immuno-oncology drug discovery. With a Ph.D. in Molecular Cell Biology from University College London, he has a robust background in biochemistry, biopharmaceuticals, and translational research. His leadership has been pivotal in guiding research teams to develop multiple clinical-stage molecules, showcasing his expertise in creating high-performing, multidisciplinary teams. Carl's career trajectory includes significant roles at renowned organizations such as Novartis and Immunitas Therapeutics, where he spearheaded innovative drug discovery initiatives. His commitment to advancing cancer therapeutics is evident through numerous publications in prestigious journals, reflecting his contributions to the field. Beyond his technical prowess, he has experience in company growth from Series A to IPO, emphasizing his business acumen in the biotech industry. Carl's passion for life sciences drives his continuous pursuit of impactful research and development in oncology.
Carl`s contact details
*********@xiliotx.com
Colleagues
Senior Vice President, Corporate Development and Program Leadership
Senior Vice President Clinical Operations
Senior Vice President Tech Ops
Director
Chief Development Officer (CDO)
Vice President Clinical Science and Pharmacovigilance
Chief Medical Officer
Chief Financial Officer and Chief Operating Officer
Founder and Chief Development Office